UNIGE document Scientific Article
previous document  unige:78652  next document
add to browser collection
Title

Longer intervals between hematopoietic stem cell transplantation and subsequent 90Y-ibritumomab radioimmunotherapy may correlate with better tolerance

Authors
Prior, John O
Allenbach, Gilles
Baechler, Sébastien
Kosinski, Marek
show hidden authors show all authors [1 - 10]
Published in Clinical Nuclear Medicine. 2012, vol. 37, no. 10, p. 960-964
Abstract This study aimed to evaluate the efficacy and toxicity of radioimmunotherapy (RIT) in recurrent lymphoma after hematopoietic stem cell transplantation (HSCT).
Keywords AdultAgedAntibodies, Monoclonal/adverse effectsFemaleHematopoietic Stem Cell Transplantation/adverse effectsHumansKaplan-Meier EstimateLymphoma/radiotherapy/surgeryMaleMiddle AgedRadioimmunotherapy/adverse effectsRecurrenceRetrospective StudiesTime FactorsTransplantation, Homologous/adverse effects
Identifiers
PMID: 22955069
Full text
This document has no fulltext available yet, but you can contact its author by using the form below.
Structures
Research group Groupe Ratib Osman (nouvelles techniques d'imagerie moléculaire) (819)
Citation
(ISO format)
BUCHEGGER, Franz et al. Longer intervals between hematopoietic stem cell transplantation and subsequent 90Y-ibritumomab radioimmunotherapy may correlate with better tolerance. In: Clinical Nuclear Medicine, 2012, vol. 37, n° 10, p. 960-964. https://archive-ouverte.unige.ch/unige:78652

40 hits

0 download

Update

Deposited on : 2015-12-15

Export document
Format :
Citation style :